2025 Part D Potential Exclusion Warning Report 2 and 2020 Reopening Exclusion Warning Report 1


The 2025 Part D Exclusion Warning Report 2 and the 2020 Part D Reopening Exclusion Warning Report 1 are now available. Please review and take the appropriate action necessary to address the Prescription Drug Event (PDE) records found in the report as outlined in previously distributed HPMS guidance on the PDE exclusion process.  

 

In the event you have questions, please contact CSSC Operations at 1-877-534-2772 (option 2) or by email at https://www.csscoperations.com.


Last Updated: 05/14/2026